Platelet and Autotransfusion Device in Cardiac Surgery
Recruiting now
Conditions studied: Platelets, Autotransfusion Device
In brief
Cardiac surgery is a bleeding-risk surgery and frequently requires blood transfusion. Intraoperative autotransfusion devices are used to aspirate, process and retransfuse patients' blood. These devices are effective in recovering red blood cells and limiting the need for transfusion of packed red blood cells. Some devices, such as I-SEP's SAME®, can also be used to recover platelets, but their effectiveness has not yet been evaluated in real-life situations. The aim of this study is therefore to investigate the evolution of platelet counts following the use of an intraoperative recovery device in adult patients undergoing standard cardiac surgery
Key facts
- Study ID
- NCT06629311
- Run by
- University Hospital, Strasbourg, France
- People needed
- 100
- Starts
- 2025-02-04
- Expected to finish
- 2026-09-08
- Last updated by the study team
- 2025-04-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients over 18 years of age
- Having undergone standard cardiac surgery (excluding redux surgery, dissection, endocarditis, circulatory assist and transplants)
- Treated with an autotransfusion device during the surgery
- Subject having expressed their consent to the study
You may not qualify if…
- Anemia less than 7 g/dL
- Pregnant women
- Redux surgery, dissection, endocarditis, circulatory assistance, and transplants
- Contraindication to the use of an autotransfusion device
- Impossibility of giving the subject informed information
Where it is running
- Hôpitaux Universitaires de Strasbourg — Strasbourg, Bas-Rhin, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.